InMed Pharmaceuticals (INM) Assets Average (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Assets Average of $10.2 million for Q1 2026, up 14.3% year-over-year from $8.9 million in Q1 2025, and down 17.22% quarter-over-quarter from $12.3 million in Q4 2025.
InMed Pharmaceuticals (INM) Assets Average (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Assets Average history runs 7 years deep, the most recent figure standing at $10.2 million for Q1 2026.
- In Q1 2026, Assets Average rose 14.3% year-over-year to $10.2 million; the TTM figure through Mar 2026 stood at $10.2 million (up 14.3% YoY), while the FY2025 annual figure was $13.7 million, up 5.68% from the prior year.
- Assets Average for Q1 2026 stood at $10.2 million, down from $12.3 million in the prior quarter.
- The five-year high for Assets Average was $17.4 million in Q1 2022, with the low at $8.9 million in Q1 2025.
- The 5-year median for Assets Average is $13.1 million (2023), against an average of $13.1 million.
- The sharpest annual moves came in 2022 and 2025: Assets Average soared 44.73% in 2022, then plunged 37.86% in 2025.
- InMed Pharmaceuticals' Assets Average stood at $15.8 million in 2022, then decreased by 16.92% to $13.1 million in 2023, then slipped by 27.53% to $9.5 million in 2024, then rose by 29.45% to $12.3 million in 2025, then decreased by 17.22% to $10.2 million in 2026.
- Business Quant data shows INM's Assets Average at $10.2 million in Q1 2026, $12.3 million in Q4 2025, and $14.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - | 10.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.16 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Sep 30, 2025 | 14.47 Mn |
| Jun 30, 2025 | 12.43 Mn |
| Mar 31, 2025 | 8.89 Mn |
| Dec 31, 2024 | 9.48 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | 12.59 Mn |
| Mar 31, 2024 | 14.31 Mn |
| Dec 31, 2023 | 13.09 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 14.42 Mn |
| Mar 31, 2023 | 15.82 Mn |
| Dec 31, 2022 | 15.75 Mn |
| Sep 30, 2022 | 13.69 Mn |
| Jun 30, 2022 | 14.14 Mn |
| Mar 31, 2022 | 17.43 Mn |
| Dec 31, 2021 | 18.36 Mn |
| Sep 30, 2021 | 13.55 Mn |
| Jun 30, 2021 | 11.06 Mn |